Jagsonpal Pharmaceuticals Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sources of funds

Owner's fund

Equity share capital

13.10

13.10

13.10

13.10

13.10

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

145.79

109.92

100.99

90.10

83.53

Loan funds

Secured loans

-

-

6.79

4.66

3.79

Unsecured loans

-

-

-

-

-

Total

158.89

123.02

120.88

107.86

100.42

Uses of funds

Fixed assets

Gross block

32.87

60.28

60.12

55.83

55.00

Less : revaluation reserve

-

7.84

7.84

7.84

7.84

Less : accumulated depreciation

8.59

35.53

34.40

33.74

33.36

Net block

24.28

16.91

17.88

14.25

13.80

Capital work-in-progress

-

-

-

4.25

3.95

Investments

1.12

42.72

15.31

11.39

-

Net current assets

Current assets, loans & advances

169.55

100.99

123.17

109.23

110.19

Less : current liabilities & provisions

36.06

37.60

35.49

31.26

27.53

Total net current assets

133.49

63.39

87.69

77.97

82.66

Miscellaneous expenses not written

-

-

-

-

-

Total

158.89

123.02

120.88

107.86

100.42

Notes:

Book value of unquoted investments

1.02

20.58

12.06

11.39

-

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

6.09

5.87

5.99

6.06

0.69

Number of equity sharesoutstanding (Lacs)

261.98

261.98

261.98

261.98

261.98